ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Lack of incremental value of three-dimensional measurement in assessing invasiveness for lung cancer

Wang, Meng-Min; Li, Jia-Qi; Dou, Shi-Hua; Li, Hong-Ji; Qiu, Zhen-Bin; Zhang, Chao; Yang, Xiong-Wen; Zhang, Jia-Tao; Qiu, Xin-Hua; Xie, Hong-Sheng; Tang, Wen-Fang; Cheng, Mei-Ling; Yan, Hong-Hong; Yang, Xue-Ning; Wu, Yi-Long; Zhang, Xue-Gong; Yang, Lin*; Zhong, Wen-Zhao*广东省人民医院; 南方医科大学; 清华大学
European Journal of Cardio-thoracic Surgery2023-12-1DOI: 10.1093/ejcts/ezad373
1被引11阅读
引用收藏
分享

摘要

OBJECTIVES: The aim of this study was to evaluate the performance of consolidation-to-tumour ratio (CTR) and the radiomic models in two- and three-dimensional modalities for assessing radiological invasiveness in early-stage lung adenocarcinoma.METHODS: A retrospective analysis was conducted on patients with early-stage lung adenocarcinoma from Guangdong Provincial People's Hospital and Shenzhen People's Hospital. Manual delineation of pulmonary nodules along the boundary was performed on cross-sectional images to extract radiomic features. Clinicopathological characteristics and radiomic signatures were identified in both cohorts. CTR and radiomic score for every patient were calculated. The performance of CTR and radiomic models were tested and validated in the respective cohorts.RESULTS: A total of 818 patients from Guangdong Provincial People's Hospital were included in the primary cohort, while 474 patients from Shenzhen People's Hospital constituted an independent validation cohort. Both CTR and radiomic score were identified as independent factors for predicting pathological invasiveness. CTR in two- and three-dimensional modalities exhibited comparable results with areas under the receiver operating characteristic curves and were demonstrated in the validation cohort (area under the curve: 0.807 vs 0.826, P = 0.059) Furthermore, both CTR in two- and three-dimensional modalities was able to stratify patients with significant relapse-free survival (P < 0.000 vs P < 0.000) and overall survival (P = 0.003 vs P = 0.001). The radiomic models in two- and three-dimensional modalities demonstrated favourable discrimination and calibration in independent cohorts (P = 0.189).CONCLUSIONS: Three-dimensional measurement provides no additional clinical benefit compared to two-dimensional.

学科与关键词

关键词
Early-stage lung adenocarcinomaSurgeryConsolidation-to-tumour ratioRadiomic models
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
European Journal of Cardio-thoracic Surgery
发表日期
2023-12-01
卷期
第 64 卷, 第 6 期
页码
ezad373
DOI
10.1093/ejcts/ezad373
语言
ENGLISH
成果收录
SCIE
资助标注
Guangdong Basic and Applied Basic Research Foundation; Guangdong Medical Association (Evidence-based medicine branch)

作者

  • W

    Wang, Meng-Min (第一作者)

    guangdong prov peoples hosp · southern med univ

  • L

    Li, Jia-Qi

    tsinghua univ

查看全部 18 位作者收起作者
  • D

    Dou, Shi-Hua

    2

  • L

    Li, Hong-Ji

    guangdong prov peoples hosp · southern med univ

  • Q

    Qiu, Zhen-Bin

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhang, Chao

    guangdong prov peoples hosp · southern med univ

  • Y

    Yang, Xiong-Wen

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhang, Jia-Tao

    guangdong prov peoples hosp · southern med univ

  • Q

    Qiu, Xin-Hua

    guangdong prov peoples hosp · southern med univ

  • X

    Xie, Hong-Sheng

    2

  • T

    Tang, Wen-Fang

    zhongshan city peoples hosp

  • C

    Cheng, Mei-Ling

    guangdong prov peoples hosp · southern med univ

  • Y

    Yan, Hong-Hong

    guangdong prov peoples hosp · southern med univ

  • Y

    Yang, Xue-Ning

    guangdong prov peoples hosp · southern med univ

  • W

    Wu, Yi-Long

    guangdong prov peoples hosp · southern med univ

  • Z

    Zhang, Xue-Gong

    tsinghua univ

  • Y

    Yang, Lin (通讯)

    2

  • Z

    Zhong, Wen-Zhao (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417